Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fuchs

Showing results (261-270 of 373) with videos related to

Pageof 38
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|August 13, 2019
CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patientsPaul J Pockros, Michael Fuchs, Bradley Freilich, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 25, 2021
Gut Microbial Signature of Hepatocellular Cancer in Men With CirrhosisSomaya Albhaisi, Amirhossein Shamsaddini, Andrew Fagan, et al.
Hemasphere|March 24, 2025
Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy: Results from the prospective GHSG-NLG phase II BVB trialAlexander Fosså, Daniel Molin, Paul J Bröckelmann, et al.
European Journal of Haematology|September 3, 2022
JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO)Sarah Gillessen, Annette Pluetschow, Vladan Vucinic, et al.
Blood|January 31, 2014
Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study GroupDennis A Eichenauer, Indra Thielen, Heinz Haverkamp, et al.
Blood|February 3, 2016
Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trialsBoris Böll, Helen Goergen, Karolin Behringer, et al.
JCI Insight|March 9, 2018
Gut microbial RNA and DNA analysis predicts hospitalizations in cirrhosisJasmohan S Bajaj, Leroy R Thacker, Andrew Fagan, et al.
Journal of Hepatology|July 18, 2020
Sex is associated with differences in gut microbial composition and function in hepatic encephalopathyKrishnakant Saboo, Amirhossein Shamsaddini, Mihir V Iyer, et al.
Journal of Lipid Research|February 14, 2025
Liver specific transgenic expression of CYP7B1 attenuates early western diet-induced MASLD progressionGenta Kakiyama, Nanah Bai-Kamara, Daniel Rodriguez-Agudo, et al.
Head & Neck|November 22, 2012
Speech rehabilitation during the first year after total laryngectomySusanne Singer, Dorit Wollbrück, Andreas Dietz, et al.
Pageof 38

Showing results (261-270 of 373) with videos related to

Sort By:
Pageof 38
Liver International : Official Journal of the International Association for the Study of the Liver|August 13, 2019
CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patientsPaul J Pockros, Michael Fuchs, Bradley Freilich, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 25, 2021
Gut Microbial Signature of Hepatocellular Cancer in Men With CirrhosisSomaya Albhaisi, Amirhossein Shamsaddini, Andrew Fagan, et al.
Hemasphere|March 24, 2025
Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy: Results from the prospective GHSG-NLG phase II BVB trialAlexander Fosså, Daniel Molin, Paul J Bröckelmann, et al.
European Journal of Haematology|September 3, 2022
JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO)Sarah Gillessen, Annette Pluetschow, Vladan Vucinic, et al.
Blood|January 31, 2014
Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study GroupDennis A Eichenauer, Indra Thielen, Heinz Haverkamp, et al.
Blood|February 3, 2016
Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trialsBoris Böll, Helen Goergen, Karolin Behringer, et al.
JCI Insight|March 9, 2018
Gut microbial RNA and DNA analysis predicts hospitalizations in cirrhosisJasmohan S Bajaj, Leroy R Thacker, Andrew Fagan, et al.
Journal of Hepatology|July 18, 2020
Sex is associated with differences in gut microbial composition and function in hepatic encephalopathyKrishnakant Saboo, Amirhossein Shamsaddini, Mihir V Iyer, et al.
Journal of Lipid Research|February 14, 2025
Liver specific transgenic expression of CYP7B1 attenuates early western diet-induced MASLD progressionGenta Kakiyama, Nanah Bai-Kamara, Daniel Rodriguez-Agudo, et al.
Head & Neck|November 22, 2012
Speech rehabilitation during the first year after total laryngectomySusanne Singer, Dorit Wollbrück, Andreas Dietz, et al.
Pageof 38